Disclosure Of Share-Based Payment Arrangements [Text Block]

OSE Immunotherapeutics - Filing #2816794

Concept 2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Disclosure of share-based payment arrangements [text block]
Expense from share-based payment transactions, alternative [abstract]
Expense from share-based payment transactions with employees
3 773 EUR
2 283 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.